Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Windecker, Stephan"" wg kryterium: Autor


Tytuł:
Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification.
Autorzy:
Ueki Y; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Zanchin T; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Losdat S; CTU Bern, University of Bern, Bern, Switzerland.
Karagiannis A; CTU Bern, University of Bern, Bern, Switzerland.
Otsuka T; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Siontis GCM; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Häner J; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Stortecky S; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Pilgrim T; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Valgimigli M; Cardiocentro, Lugano, Switzerland.
Windecker S; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Räber L; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Feb 16; Vol. 17 (2), pp. e0263180. Date of Electronic Publication: 2022 Feb 16 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Self Report*
Coronary Artery Disease/*therapy
Medication Adherence/*statistics & numerical data
Percutaneous Coronary Intervention/*methods
Purinergic P2Y Receptor Antagonists/*therapeutic use
Receptors, Purinergic P2Y12/*chemistry
Academic Medical Centers ; Aged ; Coronary Artery Disease/pathology ; Female ; Humans ; Male ; Medication Adherence/psychology ; Prospective Studies
Czasopismo naukowe
Tytuł:
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
Autorzy:
Gao C; Department of Cardiology, Xijing hospital, Xi'an, China.; Department of Cardiology, Radboud University, Nijmegen, The Netherlands.; Department of Cardiology, National University of Ireland Galway, Galway, Ireland.
Tomaniak M; First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.; Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands.
Takahashi K; Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Kawashima H; Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Cardiology, National University of Ireland Galway, Galway, Ireland.
Wang R; Department of Cardiology, Xijing hospital, Xi'an, China.; Department of Cardiology, Radboud University, Nijmegen, The Netherlands.; Department of Cardiology, National University of Ireland Galway, Galway, Ireland.
Hara H; Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Cardiology, National University of Ireland Galway, Galway, Ireland.
Ono M; Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Cardiology, National University of Ireland Galway, Galway, Ireland.
Montalescot G; Sorbonne University, ACTION Study Group, Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris, France.
Garg S; Department of Cardiology, Royal Blackburn Hospital, Blackburn, UK.
Haude M; Department of Cardiology, Rheinland Klinikum Neuss, Lukaskrankenhaus, Neuss, Germany.
Slagboom T; OLVG, Amsterdam, Netherlands.
Vranckx P; Department of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis, Hasselt, Belgium.
Valgimigli M; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Windecker S; Department of Cardiology, Bern University Hospital, Bern, Switzerland.
van Geuns RJ; Department of Cardiology, Radboud University, Nijmegen, The Netherlands.
Hamm C; Kerckhoff Heart Center, Bad Nauheim, Germany.
Steg PG; FACT, French Alliance for Cardiovascular Trials, Paris, France.; Hôpital Bichat, AP-HP, Paris, France.
Onuma Y; Department of Cardiology, National University of Ireland Galway, Galway, Ireland.
Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.
Serruys PW; Department of Cardiology, National University of Ireland Galway, Galway, Ireland. .; NHLI, Imperial College London, London, UK. .; Interventional Medicine and Innovation, National University of Ireland Galway, P.O. University Road, Galway, H91 TK33, Ireland. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2020 Oct 16; Vol. 19 (1), pp. 179. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus*/diagnosis
Diabetes Mellitus*/mortality
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/instrumentation
Percutaneous Coronary Intervention*/mortality
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/mortality
Coronary Artery Disease/*therapy
Myocardial Infarction/*therapy
Platelet Aggregation Inhibitors/*therapeutic use
Ticagrelor/*therapeutic use
Aged ; Aged, 80 and over ; Asia ; Australia ; Brazil ; Canada ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/mortality ; Drug-Eluting Stents ; Europe ; Female ; Hemorrhage/chemically induced ; Hemorrhage/mortality ; Humans ; Incidence ; Male ; Middle Aged ; Myocardial Infarction/diagnosis ; Myocardial Infarction/mortality ; Platelet Aggregation Inhibitors/adverse effects ; Prevalence ; Randomized Controlled Trials as Topic ; Recurrence ; Risk Assessment ; Risk Factors ; Secondary Prevention ; Stroke/mortality ; Stroke/prevention & control ; Ticagrelor/adverse effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experience.
Autorzy:
Lanz J; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Wyss D; Department of Cardiovascular Surgery, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Räber L; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Stortecky S; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Hunziker L; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Blöchlinger S; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Reineke D; Department of Cardiovascular Surgery, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Englberger L; Department of Cardiovascular Surgery, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Zanchin T; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Valgimigli M; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Heg D; Clinical Trials Unit, University of Bern, Bern, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Windecker S; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Pilgrim T; Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Feb 22; Vol. 14 (2), pp. e0209502. Date of Electronic Publication: 2019 Feb 22 (Print Publication: 2019).
Typ publikacji:
Journal Article
MeSH Terms:
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/methods
Percutaneous Coronary Intervention*/mortality
Percutaneous Coronary Intervention*/statistics & numerical data
Biomechanical Phenomena/*physiology
Postoperative Complications/*etiology
Postoperative Complications/*physiopathology
Rupture, Spontaneous/*etiology
ST Elevation Myocardial Infarction/*surgery
Aged ; Aged, 80 and over ; Female ; Heart Rupture/epidemiology ; Heart Rupture/etiology ; Humans ; Male ; Middle Aged ; Mortality ; Papillary Muscles/pathology ; Papillary Muscles/physiopathology ; Postoperative Complications/epidemiology ; Retrospective Studies ; Risk Factors ; Rupture, Spontaneous/epidemiology ; Rupture, Spontaneous/physiopathology ; ST Elevation Myocardial Infarction/epidemiology ; ST Elevation Myocardial Infarction/physiopathology ; ST Elevation Myocardial Infarction/rehabilitation ; Ventricular Septal Rupture/epidemiology ; Ventricular Septal Rupture/etiology ; Ventricular Septal Rupture/physiopathology
Czasopismo naukowe
Tytuł:
Age- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial Infarction.
Autorzy:
Pilgrim T; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Heg D; Institute of Social and Preventive Medicine (ISPM) and Clinical Trials Unit, Department of Clinical Research, University of Bern, Bern, Switzerland, Switzerland.
Tal K; Institute of Social and Preventive Medicine (ISPM) and Clinical Trials Unit, Department of Clinical Research, University of Bern, Bern, Switzerland, Switzerland.
Erne P; Division of Cardiology, St. Anna Hospital, Lucerne, Switzerland.
Radovanovic D; AMIS Plus Data Center, Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland.
Windecker S; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Jüni P; Institute Primary Care and Clinical Epidemiology, University of Bern, Bern, Switzerland.
Pokaż więcej
Corporate Authors:
AMIS Plus Investigators
Źródło:
PloS one [PLoS One] 2015 Sep 09; Vol. 10 (9), pp. e0137047. Date of Electronic Publication: 2015 Sep 09 (Print Publication: 2015).
Typ publikacji:
Journal Article
MeSH Terms:
Geriatrics*
Percutaneous Coronary Intervention*
Sex Characteristics*
Myocardial Infarction/*drug therapy
Myocardial Infarction/*surgery
Age Factors ; Aged ; Aged, 80 and over ; Aspirin/administration & dosage ; Clopidogrel ; Female ; Hospitals ; Humans ; Male ; Middle Aged ; Myocardial Infarction/physiopathology ; Switzerland ; Ticlopidine/administration & dosage ; Ticlopidine/analogs & derivatives ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention.
Autorzy:
Pilgrim T; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Rothenbühler M; Institute of Social and Preventive Medicine and Clinical Trials Unit, University of Bern, Bern, Switzerland.
Kalesan B; Institute of Social and Preventive Medicine and Clinical Trials Unit, University of Bern, Bern, Switzerland.
Pulver C; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Stefanini GG; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Zanchin T; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Räber L; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Stortecky S; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Jung S; Department of Neurology, Bern University Hospital, Bern, Switzerland.
Mattle H; Department of Neurology, Bern University Hospital, Bern, Switzerland.
Moschovitis A; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Wenaweser P; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Meier B; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Gsponer T; Institute of Social and Preventive Medicine and Clinical Trials Unit, University of Bern, Bern, Switzerland.
Windecker S; Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland.
Jüni P; Institute of Social and Preventive Medicine and Clinical Trials Unit, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Dec 09; Vol. 9 (12), pp. e114846. Date of Electronic Publication: 2014 Dec 09 (Print Publication: 2014).
Typ publikacji:
Journal Article
MeSH Terms:
Anemia/*mortality
Coronary Artery Disease/*complications
Percutaneous Coronary Intervention/*adverse effects
Renal Insufficiency/*mortality
Aged ; Anemia/etiology ; Anemia/pathology ; Coronary Artery Disease/mortality ; Coronary Artery Disease/therapy ; Female ; Follow-Up Studies ; Glomerular Filtration Rate ; Hemoglobins/analysis ; Humans ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Renal Insufficiency/etiology ; Renal Insufficiency/pathology ; Risk Assessment ; Risk Factors ; Survival Rate
Czasopismo naukowe
Tytuł:
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial
Autorzy:
Ono, Masafumi
Chichareon, PlyAff1, Aff2
Tomaniak, MariuszAff3, Aff4
Kawashima, Hideyuki
Takahashi, Kuniaki
Kogame, Norihiro
Modolo, RodrigoAff1, Aff5
Hara, Hironori
Gao, ChaoAff6, Aff7
Wang, RutaoAff6, Aff7
Walsh, Simon
Suryapranata, Harry
da Silva, Pedro Canas
Cotton, James
Koning, René
Akin, Ibrahim
Rensing, Benno J. W. M.
Garg, Scot
Wykrzykowska, Joanna J.
Piek, Jan J.
Jüni, Peter
Hamm, Christian
Steg, Philippe Gabriel
Valgimigli, Marco
Windecker, Stephan
Storey, Robert F.
Onuma, Yoshinobu
Vranckx, Pascal
Serruys, Patrick W.Aff20, Aff22
Pokaż więcej
Źródło:
Clinical Research in Cardiology. 109(9):1125-1139
Czasopismo naukowe
Tytuł:
Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial
Autorzy:
Tomaniak, MariuszAff1, Aff2
Chichareon, PlyAff3, Aff4
Klimczak-Tomaniak, Dominika
Takahashi, Kuniaki
Kogame, Norihiro
Modolo, RodrigoAff3, Aff6
Wang, RutaoAff7, Aff23
Ono, Masafumi
Hara, Hironori
Gao, ChaoAff7, Aff23
Kawashima, Hideyuki
Rademaker-Havinga, Tessa
Garg, Scot
Curzen, Nick
Haude, Michael
Kochman, Janusz
Gori, Tommaso
Montalescot, Gilles
Angiolillo, Dominick J.
Capodanno, Davide
Storey, Robert F.
Hamm, Christian
Vranckx, Pascal
Valgimigli, Marco
Windecker, Stephan
Onuma, Yoshinobu
Serruys, Patrick W.Aff20, Aff22
Anderson, Richard
Pokaż więcej
Źródło:
Clinical Research in Cardiology. 109(7):930-943
Czasopismo naukowe
Tytuł:
Atrial Fibrillation on Vitamin K Antagonist Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina
Autorzy:
Piccolo, Raffaele
Pilgrim, Thomas
Windecker, Stephan
Pokaż więcej
Źródło:
Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting. :1-18
Książka elektroniczna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies